Impact of leukocyte count on mortality and bleeding in patients with myocardial infarction undergoing primary percutaneous coronary interventions: Analysis from the harmonizing outcome with revascularization and stent in acute myocardial infarction trial

Circulation

Volumn 123, Issue 24, 2011, Pages 2829-2837

  Palmerini, Tullio ^a,b   Mehran, Roxana ^b   Dangas, George ^b   Nikolsky, Eugenia ^b   Witzenbichler, Bernhard ^c   Guagliumi, Giulio ^d   Dudek, Darius ^e   Genereux, Philippe ^b   Caixeta, Adriano ^b   Rabbani, Leroy ^b   Weisz, Giora ^b   Parise, Helen ^b   Fahy, Martin ^b   Xu, Ke ^b   Brodie, Bruce ^f   Lansky, Alexandra ^b   Stone, Gregg W ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b NewYork Presbyterian Hospital   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d OSPEDALI RIUNITI   (Italy)

^e JAGIELLONIAN UNIVERSITY   (Poland)

^f MOSES H CONE MEMORIAL HOSPITAL   (United States)

Author keywords

angioplasty; leukocyte count; myocardial infarction; stents

Indexed keywords

ARTICLE; BLEEDING; BLOOD CELL COUNT; CHILD; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; HAZARD RATIO; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LEUKOCYTE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CREATINE KINASE; FEMALE; HEMORRHAGE; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; RISK FACTORS; STENTS;

EID: 79959532379     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.985564     Document Type: Article

References (29)

1. Cole DR, Singian EB, Katz LN. The long-term prognosis following myocardial infarction, and some factors which affect it. Circulation. 1954;9:321-334.
2. Barron HV, Cannon CP, Murphy SA, Braunwald E, Gibson CM. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a Thrombolysis in Myocardial Infarction 10 substudy. Circulation. 2000;102:2329-2334.
3. Patel MR, Mahaffey KW, Armstrong PW, Weaver WD, Tasissa G, Hochman JS, Todaro TG, Malloy KJ, Rollins S, Theroux P, Ruzyllo W, Nicolau JC, Granger CB. Prognostic usefulness of white blood cell count and temperature in acute myocardial infarction (from the CARDINAL Trial). Am J Cardiol. 2005;95:614-618. (Pubitemid 40255251)
4. Ndrepepa G, Braun S, Iijima R, Keta D, Byrne RA, Schulz S, Mehilli J, Schomig A, Kastrati A. Total leucocyte count, but not C-reactive protein, predicts 1-year mortality in patients with acute coronary syndromes treated with percutaneous coronary intervention. Clin Sci (Lond). 2009; 116:651-658.
5. Prasad A, Stone GW, Stuckey TD, Costantini CO, Mehran R, Garcia E, Tcheng JE, Cox DA, Grines CL, Lansky AJ, Gersh BJ. Relation between leucocyte count, myonecrosis, myocardial perfusion, and outcomes following primary angioplasty. Am J Cardiol. 2007;99:1067-1071. (Pubitemid 46560465)
6. Pellizzon GG, Dixon SR, Stone GW, Cox DA, Mattos L, Boura JA, Grines LL, Addala S, O'Neill WW, Grines CL. Relation of admission white blood cell count to long-term outcomes after primary coronary angioplasty for acute myocardial infarction (the Stent PAMI Trial). Am J Cardiol. 2003;91:729-731. (Pubitemid 36287470)
7. Smit JJ, Ottervanger JP, Slingerland RJ, Kolkman JJ, Suryapranata H, Hoorntje JC, Dambrink JH, Gosselink AT, de Boer MJ, Zijlstra F, van 't Hof AW. Comparison of usefulness of C-reactive protein versus white blood cell count to predict outcome after primary percutaneous coronary intervention for ST elevation myocardial infarction. Am J Cardiol. 2008; 101:446-451. (Pubitemid 351199429)
8. Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Dangas G, Wong SC, Kirtane AJ, Parise H, Mehran R. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med. 2008;358:2218-2230. (Pubitemid 351724451)
9. Mehran R, Brodie B, Cox DA, Grines CL, Rutherford B, Bhatt DL, Dangas G, Feit F, Ohman EM, Parise H, Fahy M, Lansky AJ, Stone GW. The Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale. Am Heart J. 2008;156:44-56. (Pubitemid 351862292)
10. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344-2351. (Pubitemid 46685903)
11. Kratz A, Ferraro M, Sluss PM, Lewandrowski KB. Case records of the Massachusetts General Hospital: weekly clinicopathological exercises: laboratory reference values. N Engl J Med. 2004;351:1548-1563.
12. Halkin A, Stone GW, Grines CL, Cox DA, Rutherford BD, Esente P, Meils CM, Albertsson P, Farah A, Tcheng JE, Lansky AJ, Mehran R. Prognostic implications of creatine kinase elevation after primary percutaneous coronary intervention for acute myocardial infarction. J Am Coll Cardiol. 2006;47:951-961.
13. Shell WE, Kjekshus JK, Sobel BE. Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity. J Clin Invest. 1971;50:2614-2625.
14. Sobel BE, Bresnahan GF, Shell WE, Yoder RD. Estimation of infarct size in man and its relation to prognosis. Circulation. 1972;46:640-648.
15. Halkin A, Stone GW, Dixon SR, Grines CL, Tcheng JE, Cox DA, Garcia E, Brodie B, Stuckey TD, Mehran R, Lansky AJ. Impact and determinants of left ventricular function in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction. Am J Cardiol. 2005;96:325-331.
16. Palmerini T, Coller BS, Cervi V, Tomasi L, Marzocchi A, Marrozzini C, Leone O, Piccioli M, Branzi A. Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system. J Am Coll Cardiol. 2004;44:1570-1577. (Pubitemid 39369787)
17. Palmerini T, Nedelman MA, Scudder LE, Nakada MT, Jordan RE, Smyth S, Gordon RE, Fallon JT, Coller BS. Effects of abciximab on the acute pathology of blood vessels after arterial stenting in nonhuman primates. J Am Coll Cardiol. 2002;40:360-366. (Pubitemid 34756300)
18. Goel MS, Diamond SL. Neutrophil enhancement of fibrin deposition under flow through platelet-dependent and -independent mechanisms. Arterioscler Thromb Vasc Biol. 2001;21:2093-2098. (Pubitemid 34219767)
19. Mickelson JK, Lakkis NM, Villarreal-Levy G, Hughes BJ, Smith CW. Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease? J Am Coll Cardiol. 1996;28:345-353. (Pubitemid 26274326)
20. Thiagarajan RR, Winn RK, Harlan JM. The role of leukocyte and endo-thelial adhesion molecules in ischemia-reperfusion injury. Thromb Haemost. 1997;78:310-314. (Pubitemid 27289260)
21. Vita JA, Brennan ML, Gokce N, Mann SA, Goormastic M, Shishehbor MH, Penn MS, Keaney JF Jr, Hazen SL. Serum myeloperoxidase levels independently predict endothelial dysfunction in humans. Circulation. 2004;110:1134-1139. (Pubitemid 39319014)
22. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med. 2007;357:1121-1135.
23. Koskenkari J, Rimpilainen J, Biancari F, Surcel HM, Kaukoranta P, Kiviluoma K, Ala-Kokko T, Juvonen T. Leukocyte depleting filter attenuates myocardial injury during elective coronary artery bypass surgery. Scand Cardiovasc J. 2005;39:358-368. (Pubitemid 43135198)
24. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res. 2002;53:31-47. (Pubitemid 34020764)
25. Pocock SJ, Mehran R, Clayton TC, Nikolsky E, Parise H, Fahy M, Lansky AJ, Bertrand ME, Lincoff AM, Moses JW, Ohman EM, White HD, Stone GW. Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications: assessment from the Acute Catheterization and Urgent Intervention Triage Strategy trial. Circulation. 2010;121:43-51.
26. Despotis GJ, Levine V, Goodnough LT. Relationship between leukocyte count and patient risk for excessive blood loss after cardiac surgery. Crit Care Med. 1997;25:1338-1346. (Pubitemid 27347298)
27. Tamura A, Watanabe T, Nasu M. Association between neutrophil counts on admission and left ventricular function in patients successfully treated with primary coronary angioplasty for first anterior wall acute myocardial infarction. Am J Cardiol. 2001;88:678-680. (Pubitemid 32831105)
28. Gurm HS, Bhatt DL, Lincoff AM, Tcheng JE, Kereiakes DJ, Kleiman NS, Jia G, Topol EJ. Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials. Heart. 2003;89: 1200-1204. (Pubitemid 37164014)
29. Coller BS. Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene? Arterioscler Thromb Vasc Biol. 2005;25:658-670. (Pubitemid 40463851)